1 |
Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005
DOI
ScienceOn
|
2 |
Bajaj M, Defronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 10: 311-323, 2003
DOI
ScienceOn
|
3 |
Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J. Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 625-627, 1990
DOI
ScienceOn
|
4 |
Kawamori R, Morishima T, Kubota M, Matsuhisa M, Ikeda M, Kamada T. Influence of oral sulfonylurea agents on hepatic glucose uptake. Diabetes Res Clin Pract 28 Suppl: S109-113, 1995
DOI
ScienceOn
|
5 |
Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992
DOI
ScienceOn
|
6 |
Koike T, Tomoda F, Kinuno H, Inoue H, Takata M. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats. Acta Physiol Scand 184: 73-81, 2005
DOI
ScienceOn
|
7 |
Kumar N, Dey CS. Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. J Exp Biol 205: 3739-3746, 2002
PUBMED
|
8 |
Minami K, Morita M, Saraya A, Yano H, Terauchi Y, Miki T, Kuriyama T, Kadowaki T, Seino S. ATP-sensitive channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling. Am J Physiol Endocrinol Metab 285: E1289-1296, 2003
DOI
|
9 |
Muller G, Satoh Y, Geisen K. Extrapancreatic effects of sulfonylureas- a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract 28 Suppl: S115-137,
DOI
ScienceOn
|
10 |
Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 34: 535-542, 2004
DOI
ScienceOn
|
11 |
UKPDS. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998
DOI
PUBMED
ScienceOn
|
12 |
Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870, 1990
DOI
ScienceOn
|
13 |
Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sritharan KC, Jena BP, Geibel JP, Andersen DK. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem 15: 51-58, 2005
DOI
PUBMED
ScienceOn
|
14 |
Rodriguez E, Pulido N, Romero R, Arrieta F, Panadero A, Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology 145: 679-685, 2004
DOI
ScienceOn
|
15 |
Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. J Clin Endocrinol Metab 45: 601-604, 1977
DOI
PUBMED
|
16 |
Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes 51 Suppl 3: S368-376, 2002
DOI
ScienceOn
|
17 |
Boyd JJ, Contreras I, Kern M, Tapscott EB, Downes DL, Frisell WR, Dohm GL. Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol 259: E111-116, 1990
|
18 |
Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45: 1644-1654, 1996
DOI
PUBMED
ScienceOn
|
19 |
Mori Y, Komiya H, Kurokawa N, Tajima N. Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity. Diabetes Obes Metab 6: 28-34, 2004
DOI
ScienceOn
|
20 |
Toide K, Man ZW, Asahi Y, Sato T, Nakayama N, Noma Y, Oka Y, Shima K. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain. Diabetes Res Clin Pract 38: 151-160, 1997
DOI
ScienceOn
|
21 |
Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, Routh VH. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: 1959-1965, 2004
DOI
ScienceOn
|
22 |
Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733, 2001
DOI
ScienceOn
|
23 |
Wasada T, Yano T, Ohta M, Yui N, Iwamoto Y. ATP-Sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells. Endocr J 48: 369-375, 2001
DOI
ScienceOn
|
24 |
Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P. Glucose uptake in human adipose tissue. Metabolism 36: 1154-1160, 1987
DOI
ScienceOn
|
25 |
Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, Fisher EC, Wolfe RR, Elahi D, Evans WJ. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264: E855-862, 1993
|
26 |
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95: 2111-2119, 1995
DOI
ScienceOn
|
27 |
Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J, Seino S. Defective insulin secretion and enhanced insulin action in channel-deficient mice. Proc Natl Acad Sci U S A 95: 10402-10406, 1998
|